Business Description

GlucoTrack Inc
NAICS : 339112
SIC : 3841
Description
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 16.97 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -100 | |||||
3-Year EBITDA Growth Rate | 70.8 | |||||
3-Year EPS without NRI Growth Rate | 83.8 | |||||
3-Year FCF Growth Rate | 68.2 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.57 | |||||
9-Day RSI | 28.37 | |||||
14-Day RSI | 27.16 | |||||
6-1 Month Momentum % | -37.24 | |||||
12-1 Month Momentum % | -64.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.55 | |||||
Quick Ratio | 3.55 | |||||
Cash Ratio | 3.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.4 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -108.58 | |||||
ROA % | -85.91 | |||||
ROIC % | -1178.13 | |||||
ROC (Joel Greenblatt) % | -5516.83 | |||||
ROCE % | -102.05 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.33 | |||||
Price-to-Tangible-Book | 2.33 | |||||
EV-to-EBIT | -0.62 | |||||
EV-to-EBITDA | -0.62 | |||||
EV-to-FCF | -0.76 | |||||
Price-to-Net-Current-Asset-Value | 2.33 | |||||
Price-to-Net-Cash | 2.69 | |||||
Earnings Yield (Greenblatt) % | -161.29 |
How GlucoTrack Inc (GCTK) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GCTK
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
GlucoTrack Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.29 | ||
Beta | -0.1 | ||
Volatility % | 30.28 | ||
14-Day RSI | 27.16 | ||
14-Day ATR ($) | 0.100621 | ||
20-Day SMA ($) | 0.62901 | ||
12-1 Month Momentum % | -64.58 | ||
52-Week Range ($) | 0.3118 - 4.24 | ||
Shares Outstanding (Mil) | 15.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GlucoTrack Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
GlucoTrack Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
GlucoTrack Inc Frequently Asked Questions
What is GlucoTrack Inc(GCTK)'s stock price today?
The current price of GCTK is $0.35. The 52 week high of GCTK is $4.24 and 52 week low is $0.31.
When is next earnings date of GlucoTrack Inc(GCTK)?
The next earnings date of GlucoTrack Inc(GCTK) is 2023-05-16 Est..
Does GlucoTrack Inc(GCTK) pay dividends? If so, how much?
GlucoTrack Inc(GCTK) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |